Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
25 units = 0.25mL 0.6mg/mL = 0.15mg per injection (starter vial)
There is no Therapeutic Use Exemption pathway because BPC-157 has no approved therapeutic indication in any major jurisdiction
Oral Supplements/ nasal sprays- Ideal for mild deficiencies
Controlling the role of BPC 157 likely involves its particular interaction with the major systems involved in wound healing, such as the NO-system (counteracted harmful events, arising from either NO-blockade or NOS-substrate application) (Sikiric et al., 2014) and the prostaglandins system (i.e., large extent of the counteracted NSAIDs toxicity (Sikiric et al., 2013) as well as counteracted developing and already formed adjuvant arthritis in rats (Sikiric et al., 1997c))
US$ 21.21
US$ 24.85
US$ 27.54
